U.K. ultrasound and patient monitoring firm Kontron Instruments found a buyer last month, only weeks after going into receivership. The company was purchased Feb. 5 by Innermail Ltd., a subsidiary of Charterhouse Group International, a private equity
U.K. ultrasound and patient monitoring firm Kontron Instruments found a buyer last month, only weeks after going into receivership. The company was purchased Feb. 5 by Innermail Ltd., a subsidiary of Charterhouse Group International, a private equity company based in New York City.
At the time it went into receivership, Kontron owed roughly $8 million to its creditors. Its assets were intellectual property rights to its monitoring products, an electronic assembly plant, raw materials, and stock, according to Kontron's receiver, KPMG, an international accounting firm also based in the U.K. (SCAN 2/17/99). Ninety Kontron employees lost jobs as a result of the company's failure, although KPMG anticipates that several of these employees will be hired by Innermail. Charterhouse Group was unavailable for comment on the Kontron purchase.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.